Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-04 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −120 $242.70 $29K 24,542
2025-03-03 Hesslein Robert W. EVP, CLO and Secretary Grant or award +757 8,002
2025-03-03 Hesslein Robert W. EVP, CLO and Secretary Grant or award · Stock Option (right to buy) +1,529 1,529
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award 10b5-1 +3,871 16,256
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −204 $242.37 $49K 16,052
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −224 $243.36 $55K 15,828
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −151 $244.41 $37K 15,677
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −111 $245.26 $27K 15,566
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −45 $246.18 $11K 15,521
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −4 $247.35 $989 15,517
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −1 $248.36 $248 15,516
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −465 $242.69 $113K 15,051
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −487 $243.94 $119K 14,564
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −219 $245.30 $54K 14,345
2025-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award · Stock Option (right to buy) 10b5-1 +7,819 7,819
2025-03-03 Tanguler Tolga EVP, Chief Commercial Officer Grant or award +14,137 28,482
2025-03-03 Tanguler Tolga EVP, Chief Commercial Officer Sale −131 $242.37 $32K 28,351
2025-03-03 Tanguler Tolga EVP, Chief Commercial Officer Sale −142 $243.36 $35K 28,209
2025-03-03 Tanguler Tolga EVP, Chief Commercial Officer Sale −96 $244.41 $23K 28,113
2025-03-03 Tanguler Tolga EVP, Chief Commercial Officer Sale −70 $245.26 $17K 28,043

Page 31 of 41 · 816 trades